Prothena’s fair value estimate has been nudged higher from $18.33 to $20.33 per share as analysts grow more confident in the company’s partnered pipeline and its potential to drive stronger long term revenue. The model now assumes faster…
How the Narrative Surrounding Prothena Is Changing After New Pipeline and Valuation Updates
